GAPDH and prostate cancer: Using castration-resistant prostate cancer cells, miR-644a was found to be a potent tumor suppressor that can inhibit glycolytic activity and the expression of the key glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in vitro and in xenograft models [46].